[HTML][HTML] Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

M Loi, L Gennaccaro, C Fuchs, S Trazzi… - International Journal of …, 2021 - mdpi.com
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder.

M Loi, L Gennaccaro, C Fuchs… - International …, 2021 - search.ebscohost.com
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

[PDF][PDF] Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

M Loi, L Gennaccaro, C Fuchs, S Trazzi… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

M Loi, L Gennaccaro, C Fuchs… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

M Loi, L Gennaccaro, C Fuchs, S Trazzi… - INTERNATIONAL …, 2021 - cris.unibo.it
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder.

M Loi, L Gennaccaro, C Fuchs, S Trazzi… - … Journal of Molecular …, 2021 - europepmc.org
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

[HTML][HTML] Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

M Loi, L Gennaccaro, C Fuchs, S Trazzi… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

M Loi, L Gennaccaro, C Fuchs, S Trazzi, G Medici… - 2021 - agris.fao.org
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

[PDF][PDF] Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder

M Loi, L Gennaccaro, C Fuchs, S Trazzi, G Medici… - Int. J. Mol. Sci, 2021 - cris.unibo.it
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder.

M Loi, L Gennaccaro, C Fuchs, S Trazzi… - … Journal of Molecular …, 2021 - europepmc.org
Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a rare
neurodevelopmental disorder characterized by early-onset seizures and severe cognitive …